Canada Pension Plan Investment Board
AGIO icon

Canada Pension Plan Investment Board’s Agios Pharmaceuticals AGIO Stock Holding History

Canada Pension Plan Investment Board’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$612K Sell
16,500
-7,900
-32% -$240K ﹤0.01% 1191
2026
Q1 		$825K Buy
24,400
+6,200
+34% +$176K ﹤0.01% 1061
2025
Q4 		$495K Buy
+18,200
New +$639K ﹤0.01% 1306
2022
Q3 		– Sell
-121
Closed -$3K – 1192
2022
Q2 		$3K Hold
121
– – ﹤0.01% 1232
2022
Q1 		$4K Hold
121
– – ﹤0.01% 1290
2021
Q4 		$4K Sell
121
-606
-83% -$24.4K ﹤0.01% 1412
2021
Q3 		$34K Sell
727
-2,200
-75% -$106K ﹤0.01% 1306
2021
Q2 		$161K Sell
2,927
-3,918
-57% -$219K ﹤0.01% 972
2021
Q1 		$353K Sell
6,845
-16,635
-71% -$824K ﹤0.01% 1098
2020
Q4 		$1.02M Buy
+23,480
New +$928K ﹤0.01% 1007
2020
Q3 		– Sell
-32,886
Closed -$1.76M – 1085
2020
Q2 		$1.76M Sell
32,886
-40,800
-55% -$1.89M ﹤0.01% 773
2020
Q1 		$2.61M Sell
73,686
-18,700
-20% -$864K 0.01% 669
2019
Q4 		$4.41M Buy
92,386
+51,581
+126% +$1.95M 0.01% 655
2019
Q3 		$1.32M Buy
40,805
+19,039
+87% +$788K ﹤0.01% 912
2019
Q2 		$1.09M Buy
+21,766
New +$1.16M ﹤0.01% 1030
2018
Q1 		– Sell
-49,300
Closed -$2.82M – 1223
2017
Q4 		$2.82M Buy
49,300
+3,400
+7% +$214K 0.01% 823
2017
Q3 		$3.06M Sell
45,900
-2,200
-5% -$132K 0.01% 766
2017
Q2 		$2.48M Buy
48,100
+17,600
+58% +$900K 0.01% 789
2017
Q1 		$1.78M Buy
30,500
+18,400
+152% +$882K ﹤0.01% 822
2016
Q4 		$505K Sell
12,100
-2,400
-17% -$126K ﹤0.01% 853
2016
Q3 		$766K Buy
14,500
+3,500
+32% +$152K ﹤0.01% 823
2016
Q2 		$461K Sell
11,000
-100
-0.9% -$4.94K ﹤0.01% 887
2016
Q1 		$451K Buy
11,100
+4,000
+56% +$171K ﹤0.01% 925
2015
Q4 		$461K Buy
7,100
+6,300
+788% +$413K ﹤0.01% 923
2015
Q3 		$56K Buy
800
+200
+33% +$19.5K ﹤0.01% 1158
2015
Q2 		$67K Buy
+600
New +$64.6K ﹤0.01% 1166

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Canada Pension Plan Investment Board's AGIO Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Agios Pharmaceuticals (AGIO) stake by 32% in Q2 2026, selling an estimated $240K and leaving 16,500 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

Canada Pension Plan Investment Board first reported a position in AGIO in Q2 2015 and has held it in 26 quarters since. The position peaked at $4.41M in Q4 2019. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Canada Pension Plan Investment Board held 16,500 shares of Agios Pharmaceuticals worth $612K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 7,900 Agios Pharmaceuticals shares in Q2 2026, an estimated $240K.
  • Agios Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1191 holding.
  • Canada Pension Plan Investment Board first reported a position in Agios Pharmaceuticals in Q2 2015 and has held it in 26 quarters since.
  • Canada Pension Plan Investment Board's Agios Pharmaceuticals position peaked at $4.41M in Q4 2019.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.